Harmen Beurmanjer

174 Supplements Supplement II Cognitive impairments in patients with GHB use disorder predict relapse in GHB use Beurmanjer H. Bruijnen C.J.W.H., Greeven P.G.J., De Jong C.A.J., Schellekens A.F.A, Dijkstra B.A.G. Table 1 Correlations between MoCA scores, GHB use, GHB exposure and number of GHB induced coma’s MoCA scores T1 MoCA scores T2 Daily GHB dose -.152 .111 Months of daily GHB use -.180 .202 Months of general GHB use -.143 .167 GHB exposure score -.217 .217 Number of GHB induced coma’s .978 -.079 MoCA cut off T1 MoCA cut off T2 Daily GHB dose -.075 .109 Months of daily GHB use .020 -.093 Months of general GHB use .129 -.192 GHB exposure score .137 .147 Number of GHB induced coma’s .979 -.079 *p <.05